Tower Research Capital (TRC)’s Surface Oncology, Inc. Common Stock SURF Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-6,726
| Closed | -$5.85K | – | 6387 |
|
2023
Q2 | $5.85K | Buy |
6,726
+6,635
| +7,291% | +$5.77K | ﹤0.01% | 4758 |
|
2023
Q1 | $0 | Sell |
91
-4,200
| -98% | – | ﹤0.01% | 6559 |
|
2022
Q4 | $3K | Sell |
4,291
-33,009
| -88% | -$23.1K | ﹤0.01% | 5290 |
|
2022
Q3 | $39K | Buy |
37,300
+32,306
| +647% | +$33.8K | ﹤0.01% | 3391 |
|
2022
Q2 | $8K | Sell |
4,994
-19,797
| -80% | -$31.7K | ﹤0.01% | 4732 |
|
2022
Q1 | $72K | Buy |
24,791
+22,745
| +1,112% | +$66.1K | ﹤0.01% | 2444 |
|
2021
Q4 | $10K | Buy |
2,046
+914
| +81% | +$4.47K | ﹤0.01% | 4637 |
|
2021
Q3 | $9K | Sell |
1,132
-6,492
| -85% | -$51.6K | ﹤0.01% | 4489 |
|
2021
Q2 | $57K | Sell |
7,624
-1,059
| -12% | -$7.92K | ﹤0.01% | 2922 |
|
2021
Q1 | $68K | Sell |
8,683
-2,004
| -19% | -$15.7K | ﹤0.01% | 2876 |
|
2020
Q4 | $99K | Buy |
10,687
+10,487
| +5,244% | +$97.1K | ﹤0.01% | 2359 |
|
2020
Q3 | $1K | Buy |
+200
| New | +$1K | ﹤0.01% | 4756 |
|
2020
Q2 | – | Sell |
-10,712
| Closed | -$20K | – | 5076 |
|
2020
Q1 | $20K | Buy |
10,712
+4,871
| +83% | +$9.09K | ﹤0.01% | 1724 |
|
2019
Q4 | $11K | Sell |
5,841
-19,656
| -77% | -$37K | ﹤0.01% | 2301 |
|
2019
Q3 | $36K | Buy |
25,497
+19,482
| +324% | +$27.5K | ﹤0.01% | 2034 |
|
2019
Q2 | $17K | Sell |
6,015
-8,021
| -57% | -$22.7K | ﹤0.01% | 2284 |
|
2019
Q1 | $67K | Buy |
14,036
+11,380
| +428% | +$54.3K | ﹤0.01% | 1629 |
|
2018
Q4 | $11K | Buy |
2,656
+845
| +47% | +$3.5K | ﹤0.01% | 2421 |
|
2018
Q3 | $20K | Buy |
+1,811
| New | +$20K | ﹤0.01% | 2361 |
|